Listed

Replimune Group, Inc.: Form 10-K for the period ended Mar 31, 2019

Filed with the SEC on Jun 28, 2019 and accepted by EDGAR at Jun 28, 2019, 17:10 ET.

Share

Sections

The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.

Figures reported in this filing

Standardized line items from the XBRL in this filing, for the period ended 2019-03-31. Comparative periods it repeats are left out.

Figures reported in this filing
Line itemPeriodValueXBRL concept
Research and development12 months2018-04-01 to 2019-03-31$22.2mus-gaap:ResearchAndDevelopmentExpense
Operating income12 months2018-04-01 to 2019-03-31−$30.9mus-gaap:OperatingIncomeLoss
Income tax12 months2018-04-01 to 2019-03-31$0us-gaap:IncomeTaxExpenseBenefit
Net income3 months2019-01-01 to 2019-03-31−$6.7mus-gaap:NetIncomeLoss
Net income12 months2018-04-01 to 2019-03-31−$30.8mus-gaap:NetIncomeLoss
Diluted EPS3 months2019-01-01 to 2019-03-31−$0.29us-gaap:EarningsPerShareBasicAndDiluted
Diluted EPS12 months2018-04-01 to 2019-03-31−$1.33us-gaap:EarningsPerShareBasicAndDiluted
Operating cash flow12 months2018-04-01 to 2019-03-31−$25.4mus-gaap:NetCashProvidedByUsedInOperatingActivities
Capital expenditure12 months2018-04-01 to 2019-03-31$2.6mus-gaap:PaymentsToAcquirePropertyPlantAndEquipment
Cash and equivalentsAt period end2019-03-31$25.7mus-gaap:CashAndCashEquivalentsAtCarryingValue
Current assetsAt period end2019-03-31$141.0mus-gaap:AssetsCurrent
Total assetsAt period end2019-03-31$154.3mus-gaap:Assets
Current liabilitiesAt period end2019-03-31$9.9mus-gaap:LiabilitiesCurrent
Total liabilitiesAt period end2019-03-31$16.5mus-gaap:Liabilities
Shareholders' equityAt period end2019-03-31$137.9mus-gaap:StockholdersEquity

Source: SEC EDGAR, the filing index for accession 0001047469-19-003946. Last ingested by Listed: Nov 3, 2026, 23:32 ET. Listed shows no prices and gives no investment advice.